Open AccessMesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses
Author(s) -
Qianqian Chen
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i29.4702
Subject(s) - foxp3 , mesenchymal stem cell , stem cell , rar related orphan receptor gamma , immunology , colitis , inflammatory bowel disease , medicine , bone marrow , cancer research , gata3 , biology , immune system , pathology , microbiology and biotechnology , transcription factor , disease , biochemistry , gene
To investigate the potential therapeutic effects of mesenchymal stem cells (MSCs) in inflammatory bowel disease (IBD), we transplanted MSCs into an experimental model of IBD.